183 related articles for article (PubMed ID: 29893509)
21. Platelet production from induced pluripotent stem cells.
Sugimoto N; Eto K
J Thromb Haemost; 2017 Sep; 15(9):1717-1727. PubMed ID: 28752663
[TBL] [Abstract][Full Text] [Related]
22. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells.
Nakamura S; Takayama N; Hirata S; Seo H; Endo H; Ochi K; Fujita K; Koike T; Harimoto K; Dohda T; Watanabe A; Okita K; Takahashi N; Sawaguchi A; Yamanaka S; Nakauchi H; Nishimura S; Eto K
Cell Stem Cell; 2014 Apr; 14(4):535-48. PubMed ID: 24529595
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal actions of platelet-secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells.
Anitua E; Sanchez M; Nurden AT; Zalduendo M; de la Fuente M; Azofra J; Andia I
Plast Reconstr Surg; 2007 Mar; 119(3):950-9. PubMed ID: 17312501
[TBL] [Abstract][Full Text] [Related]
24. Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes.
Pogozhykh D; Eicke D; Gryshkov O; Wolkers WF; Schulze K; Guzmán CA; Blasczyk R; Figueiredo C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081128
[TBL] [Abstract][Full Text] [Related]
25. Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.
Zhang N; Newman PJ
J Tissue Eng Regen Med; 2019 Feb; 13(2):244-252. PubMed ID: 30556311
[TBL] [Abstract][Full Text] [Related]
26. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets.
Ben-Ezra J; Sheibani K; Hwang DL; Lev-Ran A
Am J Pathol; 1990 Oct; 137(4):755-9. PubMed ID: 2221009
[TBL] [Abstract][Full Text] [Related]
27. Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.
Eicke D; Baigger A; Schulze K; Latham SL; Halloin C; Zweigerdt R; Guzman CA; Blasczyk R; Figueiredo C
Sci Rep; 2018 Jul; 8(1):10146. PubMed ID: 29977045
[TBL] [Abstract][Full Text] [Related]
28. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
[TBL] [Abstract][Full Text] [Related]
29. Generation of functional platelets from canine induced pluripotent stem cells.
Nishimura T; Hatoya S; Kanegi R; Sugiura K; Wijewardana V; Kuwamura M; Tanaka M; Yamate J; Izawa T; Takahashi M; Kawate N; Tamada H; Imai H; Inaba T
Stem Cells Dev; 2013 Jul; 22(14):2026-35. PubMed ID: 23409943
[TBL] [Abstract][Full Text] [Related]
30. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.
Nakagawa Y; Nakamura S; Nakajima M; Endo H; Dohda T; Takayama N; Nakauchi H; Arai F; Fukuda T; Eto K
Exp Hematol; 2013 Aug; 41(8):742-8. PubMed ID: 23618622
[TBL] [Abstract][Full Text] [Related]
31. Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.
Sim X; Poncz M; Gadue P; French DL
Blood; 2016 Mar; 127(10):1227-33. PubMed ID: 26787738
[TBL] [Abstract][Full Text] [Related]
32. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function.
Soslau G; Morgan DA; Jaffe JS; Brodsky I; Wang Y
Cytokine; 1997 Jun; 9(6):405-11. PubMed ID: 9199874
[TBL] [Abstract][Full Text] [Related]
33. Personalized platelet transfusions: one step closer to the clinic.
Noh JY; Weiss MJ; Poncz M
Cell Stem Cell; 2014 Apr; 14(4):425-6. PubMed ID: 24702993
[TBL] [Abstract][Full Text] [Related]
34. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.
Ito Y; Nakamura S; Sugimoto N; Shigemori T; Kato Y; Ohno M; Sakuma S; Ito K; Kumon H; Hirose H; Okamoto H; Nogawa M; Iwasaki M; Kihara S; Fujio K; Matsumoto T; Higashi N; Hashimoto K; Sawaguchi A; Harimoto KI; Nakagawa M; Yamamoto T; Handa M; Watanabe N; Nishi E; Arai F; Nishimura S; Eto K
Cell; 2018 Jul; 174(3):636-648.e18. PubMed ID: 30017246
[TBL] [Abstract][Full Text] [Related]
35. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.
Chen SJ; Sugimoto N; Eto K
Int J Hematol; 2023 Mar; 117(3):349-355. PubMed ID: 36574167
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional profile of platelets and iPSC-derived megakaryocytes from whole-genome and RNA sequencing.
Kammers K; Taub MA; Rodriguez B; Yanek LR; Ruczinski I; Martin J; Kanchan K; Battle A; Cheng L; Wang ZZ; Johnson AD; Leek JT; Faraday N; Becker LC; Mathias RA
Blood; 2021 Feb; 137(7):959-968. PubMed ID: 33094331
[TBL] [Abstract][Full Text] [Related]
38. Growth factor production by a human megakaryocytic tumor cell line.
Witte DP; Stambrook PJ; Feliciano E; Jones CL; Lieberman MA
J Cell Physiol; 1988 Oct; 137(1):86-94. PubMed ID: 3049629
[TBL] [Abstract][Full Text] [Related]
39. Applications of the regenerative capacity of platelets in modern medicine.
Cecerska-Heryć E; Goszka M; Serwin N; Roszak M; Grygorcewicz B; Heryć R; Dołęgowska B
Cytokine Growth Factor Rev; 2022 Apr; 64():84-94. PubMed ID: 34924312
[TBL] [Abstract][Full Text] [Related]
40. Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.
Borst S; Sim X; Poncz M; French DL; Gadue P
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2007-2013. PubMed ID: 28982668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
